Chawla Lakhmir S 4

What Happened Lakhmir S. Chawla, a director of Revelation Biosciences, reported a disposition of 2,261 shares on 2026-02-03 to satisfy tax withholding obligations tied to the vesting of restricted stock awards. The shares were disposed at a weighted average price of $1.85 per share for proceeds of approximately $4,183. The transaction is coded as F (payment of exercise price or tax liability) and was mandatory to cover taxes.

Key Details

• Transaction date: 2026-02-03; Form 4 filed 2026-02-05 (no late filing indicated in this report).
• Shares sold/disposed: 2,261 (post 1-for-4 reverse split; see note below).
• Price: weighted average $1.85; sales occurred in multiple trades at prices ranging $1.84–$1.87.
• Purpose: Issuer sold shares on behalf of the reporting person solely to satisfy required tax obligations upon RSU vesting; sale was mandatory and not at the reporting person’s discretion.
• Shares owned after the transaction: not specified in the provided filing data.

Context This was a routine tax-withholding sale (code F) following RSU vesting, not an open-market discretionary sale. Such mandatory withholdings are common and generally do not signal the insider’s view on the company’s prospects. The footnotes note that all share counts reflect a 1-for-4 reverse split effective January 28, 2026.